![Jon W. Osgood](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jon W. Osgood
Gründer bei
Cutlass Capital LLC
Profil
Mr. Jon W.
Osgood is Co-Founder & Managing Member at Cutlass Capital LLC since August 2001.
Prior to co-founding Cutlass Capital, Mr. Osgood was a Research Analyst at Deutsche Banc Alex.
Brown and its predecessors from 1983 to 2000.
He was Global Head of Health Care Research from 1984 until 2000, and headed one of the largest health care research departments on Wall Street with over 40 professionals worldwide.
His industry analytical responsibilities included every sector of health care, with special emphasis on medical technology and health care information systems.
Mr. Osgood was elected several times to the Institutional Investor All-America Research Team and was named a Wall Street Journal All-Star for his stock picking ability.
Mr. Osgood earned a BA (Magna Cum Laude and Phi Beta Kappa) from Dartmouth College and an MBA (Amos Tuck Scholar) from the Amos Tuck School of Business Administration at Dartmouth.
Aktive Positionen von Jon W. Osgood
| Unternehmen | Position | Beginn |
|---|---|---|
Cutlass Capital LLC
 Cutlass Capital LLC Investment ManagersFinance Cutlass Capital seeks investment opportunities in companies located in the United States. The firm focusses on companies operating in the field of health care industry with an investment size ranging between $3 million to $7 million. They provide equity financing for early to later stage transactions and act as a lead investor and co-investor | Gründer | 01.01.2001 |
Ehemalige bekannte Positionen von Jon W. Osgood
| Unternehmen | Position | Ende |
|---|---|---|
| BAXANO SURGICAL INC | Direktor/Vorstandsmitglied | 03.06.2013 |
Cash Reserve Fund, Inc.
 Cash Reserve Fund, Inc. Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Corporate Officer/Principal | 31.12.1999 |
| BAXANO SURGICAL INC | Direktor/Vorstandsmitglied | - |
Hemosphere, Inc.
 Hemosphere, Inc. Medical SpecialtiesHealth Technology Engages in the development and commercialization of vascular access devices | Direktor/Vorstandsmitglied | - |
CardioKinetix, Inc.
 CardioKinetix, Inc. Medical SpecialtiesHealth Technology Develops ventricular partitioning device for heart failure disease | Direktor/Vorstandsmitglied | - |
Ausbildung von Jon W. Osgood
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
48
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Cash Reserve Fund, Inc.
Cash Reserve Fund, Inc. Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
MORPHIC MEDICAL INC
 MORPHIC MEDICAL INC Medical SpecialtiesHealth Technology Designs, develops, and markets medical devices for the treatment of diabetes and obesity, and their complexities | Health Technology |
Xoft, Inc.
 Xoft, Inc. Data Processing ServicesTechnology Services Provides electronic brachytherapy technology services | Technology Services |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cutlass Capital LLC
Cutlass Capital LLC Investment ManagersFinance Cutlass Capital seeks investment opportunities in companies located in the United States. The firm focusses on companies operating in the field of health care industry with an investment size ranging between $3 million to $7 million. They provide equity financing for early to later stage transactions and act as a lead investor and co-investor | Finance |
TranS1, Inc.
 TranS1, Inc. Medical SpecialtiesHealth Technology Designs and develops surgical procedures and equipment for back pain | Health Technology |
Hemosphere, Inc.
Hemosphere, Inc. Medical SpecialtiesHealth Technology Engages in the development and commercialization of vascular access devices | Health Technology |
CardioKinetix, Inc.
CardioKinetix, Inc. Medical SpecialtiesHealth Technology Develops ventricular partitioning device for heart failure disease | Health Technology |
Wählen Sie MarketScreener 
